Introduction
Integration of human immunodeficiency virus type 1 (HIV-1) cDNA into the host chromosomal DNA is one of the crucial events in the virus's life cycle, essentially controlling the entire replication and assembly process. 1 This event is mediated by the viral integrase (IN) protein which is encapsidated within virions and released into the cell cytoplasm following virus cell fusion. 2 Within the cytoplasm, IN attaches to the viral cDNA, forming an IN-DNA complex which is part of the viral pre-integration complex (PIC). 3 For integration to occur, the IN-DNA complex has to be translocated into the infected cells' nuclei and reach the chromosomal DNA. 4 Indeed, in contrast to other retroviruses, HIV-1 can infect terminally differentiated cells. 5, 6 HIV-1's capacity to infect cell cycle-arrested cells has been ascribed to the ability of its PIC 7, 8 to translocate across the nuclear envelope via the nuclear pore complex (NPC). 9, 10 However, despite extensive effort and numerous studies, our understanding of the events leading to nuclear import of the PIC is still very poor. In particular, the detailed mechanism of the PIC's nuclear-import pathway, as well Unlike other retroviruses, human immunodeficiency virus type-1 (HIV-1) can infect terminally differentiated cells, due to the ability of its pre-integration complex (PIC) to translocate via the host nuclear pore complex (NPC). The PIC Nuclear import has been suggested to be mediated by the viral integrase protein (IN), via either the importin α or transportin 3 (TNPO3/transportin-SR2) pathways.
We show that in virus-infected cells, IN interacts with both importin α and TNPO3, simultaneously or separately, suggesting a multiple use of nuclear import pathways. Disruption of either the IN-importin α or IN-TNPO3 complexes in virus-infected cells by specific cell-permeable-peptides resulted in inhibition of IN and viral cDNA nuclear import. Here we show that peptides which disrupt either one of these complexes block virus infection, indicating involvement of both pathways in efficient viral replication. Formation of IN-importin α and IN-TNPO3 complexes has also been observed in IN-transfected cultured cells. Using specific peptides, we demonstrate that in transfected cells but not in virus infected cells the importin α pathway overrides that of TNPO3. The IN-importin α and IN-TNPO3 complexes were not observed in virus-infected Rev-expressing cells, indicating the Rev protein's ability to disrupt both complexes.
Our work suggests that IN nuclear import requires the involvement of both importin α and TNPO3. The ability to inhibit nuclear import of the IN-DNA complex and consequently, virus infection by peptides that interrupt IN's interaction with either importin α or TNPO3 indicates that for efficient infection, nuclear import of IN should be mediated by both nuclear-import receptors.
Transportin 3 and importin α are required for effective nuclear import of HIV-1 integrase in virus-infected cells
IN interacts with both importin α and TNPO3. These results suggest that these two nuclear-import receptors are involved in the translocation of IN into nuclei of infected cells, either concurrently or alternately. We have previously shown (reviewed in ref. 18 and see also Figure 1B and C) that cell-permeable peptides bearing the SV40-NLS or the putative NLS of IN (NLS-IN) can disrupt the complex formed between IN and importin α and inhibit translocation of IN into the nuclei of infected cells. As shown in Figure 1B and C, these two peptides failed to promote dissociation of the IN-TNPO3 complex, indicating that different domains mediate the interaction of IN with these two nuclearimport receptors. The results in Figure 1 also show that neither peptide had any effect on the interaction between Rev and IN, shown by us previously to occur in virus-infected cells [40] [41] [42] [43] [44] and indicating specificity of function.
Disruption of the IN-TNPO3 complex by IN-interacting peptides blocks nuclear import of IN and viral cDNA.
Three IN-interacting cell permeable peptides were previously selected by us. [45] [46] [47] [48] These peptides, termed IN-1, 45, 47 Rev 53-67 ( Fig. 2A and B) and Rev 13-23, 46, 48 (not shown respectively), have been shown to promote dissociation of the IN-TNPO3 complex but not of the IN-importin α complex. Specificity of these peptides' functions should be inferred from results showing that a peptide bearing the NLS sequence of the Rev protein [also known as the arginine-rich motif (ARM) 44, 49 ] fails to disrupt IN interactions with either importin α or TNPO3 (Fig. 2C) . However, as expected, the Rev ARM peptide was able to promote dissociation of the Rev-importin β complex ( Fig. 2D) . Also, and as shown previously, 44 only Rev 53-67 ( Fig. 2B) 14, 17, 18 Concurrent with inhibition of IN nuclear import, these two peptides blocked HIV-1 replication in virus-infected cells. 18 Inhibition was due to these peptides' ability to disrupt the interaction of IN with importin α, 17, 18 supporting the view that this nuclear-import receptor is required for virus replication in cell cycle-arrested cells.
The results of the present work, based on co-immunoprecipitation (co-IP) and immunostaining experiments and the use of cellpermeable functional peptides, indicate that in addition to importin α, TNPO3 is involved in nuclear import of IN in virus-infected cells. Our work indicates that the requirement of one nuclear receptor, importin α, does not eliminate the involvement of a second one-TNPO3. It appears that both receptors are required to allow efficient translocation of IN, and thus of the entire PIC, into host-cell nuclei. This observation may assist in solving what has appeared, until now, to be a point of contention: nuclear import of IN via the importin α 14-18 versus TNPO3, [21] [22] [23] pathway.
Results

IN interacts with both importin α and TNPO3.
Whether nuclear import of HIV-1 IN is mediated by importin α [14] [15] [16] [17] [18] or TNPO3, [21] [22] [23] is unclear and under dispute. The co-IP experiments depicted in Figure 1A show that in virus-infected cells, expected to lead to cytoplasmic retention of IN as well. Although the Rev-IN complex can be observed in the PICs of the infected cells, 40,44 a large portion of it is localized within the cytoplasm 42 and is not necessarily associated with the PIC. This is probably due to the fact that Rev promotes dissociation of the IN from the PIC localized viral cDNA. 44 The effect of the IN-interacting peptides on nuclear import of IN protein in transfected cultured cells. In light of the above and previous results 18, 42 observed in virus-infected cells, it was of interest to study the effect of the IN-interacting peptides on the intracellular localization of IN in transfected cultured cells. In transfected cells, as opposed to virus-infected cells, Rev 53-67 (and Rev 13-23, not shown), as well as IN-1, only partially inhibit nuclear import of the expressed IN (Fig.  5A) . Specificity of inhibition could be inferred from the fact that nuclear import of the Rev protein was not affected by these peptides (Fig. 5B) . On the other hand, the Rev ARM peptide, as expected, blocked nuclear import of Rev but not of IN ( Fig. 5A and B) .
The three above-described IN-interacting peptides inhibited nuclear import of IN in infected cells ( Fig. 3 , Table 1 and reviewed in ref. 42 ), most likely due to their ability to disrupt the IN-TNPO3 complex. The same three peptides were also found to inhibit nuclear import of the viral cDNA ( Fig. 4A) , as well as the appearance of 2LTR (long terminal repeat) circles. These circles can be formed only in the nuclei of infected cells following the PIC nuclear import 24 (Fig. 4B) . The Rev-NES peptide, 50 which has been used as a negative control, did not have any effect on either nuclear import of viral DNA (Fig. 4A) or the formation of the 2LTR circles ( Fig. 4B) . It should be noted that in virus-infected cells, the Rev ARM peptide, as expected, blocked nuclear import of Rev. However, the Rev ARM peptide also partially inhibited nuclear import of IN ( Fig. 3 and Table 1 ) despite its inability to disrupt the interaction between IN and its nuclear receptors (Fig. 2C) full-length Rev protein blocks IN nuclear import, 42 it was essential to study the effect of Rev itself on the interactions between IN and the nuclear-import receptors. When Rev-expressing cells were infected with HIV-1, IN failed to interact with either importin α or TNPO3 (Fig. 6) . This was inferred from the co-IP experiment showing that, in contrast to the Rev-derived peptides, the Rev protein promotes disruption of both the IN-importin α and IN-TNPO3 complexes.
Discussion
The results of the present work show that in virus-infected cells IN interacts with both importin α and TNPO3. Our previous observation showed that nuclear import of HIV-1 IN is mediated by a specific NLS domain (amino acids 161-173, NLS-IN), which mediates its translocation via the importin α pathway. 15, 17, 18, 35 This was demonstrated by import of BSA molecules Furthermore, rapid removal of CA from the RTC (reverse transcriptase complex)/PIC has been suggested to be required for nuclear import of the HIV-1 PIC. 33 Thus, a functional interaction between TNPO3 and CA remains to be proven. Our conclusion that nuclear import of IN requires the involvement of both importin α and TNPO3 and plays a dominant role in HIV-1 infection is based mainly on results obtained using two groups of peptides (Fig. 7A) . One group, which includes SV40-NLS as well as NLS-IN, 18 disrupted only-and specifically-the interaction between IN and importin α (Fig. 7A) . The second group, which includes the two Rev-derived peptides and IN-1, disrupted only the interaction between IN and TNPO3 (Fig. 7A) . Interestingly, the Rev protein which, similar to the Rev-derived peptides, has been shown to block nuclear import of IN, 42 prevented interaction of IN with both receptors. The disruption of the IN-TNPO3 complex by the Rev derived and IN-1 peptides is not necessarily due to direct masking of the TNPO3 binding sites. This can also be due to the peptides inducing a change in the IN oligomeric state [45] [46] [47] which may prevent binding of TNPO3. conjugated to the NLS-IN peptides into nuclei of permeabilized cultured cells. 17 Moreover, we have showed that cell-permeable peptides bearing NLS-IN, as well as those bearing SV40-NLS, were able to inhibit nuclear import of IN in transfected and virus-infected cultured cells. 18 As would be expected, the same peptides inhibit HIV-1 infection of TZM-bl and lymphocyte-cultured cells. 18 Recently, our observations regarding the interaction between the viral IN and importin α(3) in virus infected cells have been confirmed in independent studies using in-vitro pull-down assay and cell-based co-immunoprecipitation method in 293T cells and HIV-1 infected cells. 51 Furthermore, a short hairpin RNA (ShRNA) was employed to knockdown Impα3 in dividing C8166T, HeLa cells and non-dividing monocyte-derived macrophages (MDM). HIV-1 replication in Impα3 knockdown cells was significantly downregulated, (reviewed in ref. 51 and 52) .
The use of cell-permeable peptides allowed us to demonstrate that TNPO3, in addition to importin α, is required for mediation of IN nuclear import and virus replication in infected cells. However, our co-IP experiments did not allow us to determine whether IN interacts directly with TNPO3, as was demonstrated recently using an in-vitro assay system, 53 or if its interaction is mediated by a third component, such as t-RNA. 22 The identification of TNPO3 as a binding partner of IN has recently been confirmed independently and the IN binding site for TNPO3 has been elucidated. 54 The requirement of TNPO3 for HIV replication was based previously 21-23 mainly on the significantly low level of HIV-1 replication in RNAi TNPO3-knockdown cultured cells. Our present study, demonstrating inhibition of HIV-1 infection following disruption of the IN-TNPO3 complex by the Rev-derived peptides as well as by IN-1, strongly supports involvement of TNPO3 in the HIV-1 infection process. However, the way in which TNPO3 participates in the HIV-1 replication cycle or is involved in nuclear import of the PIC is still under debate. Christ et al. 21 and Luban 22 suggest that TNPO3 is required to mediate nuclear import of HIV-1 IN and thus for translocation of the PIC into nuclei of infected cells and consequently, for virus infection. Our demonstration of Rev-derived and IN-1 peptides disruption of the IN-TNPO3 interaction and virus infection supports this view. On the other hand, the use of MuLV/HIV chimera viruses failed to demonstrate the requirement of IN-TNPO3 interaction for HIV replication. 53 Krishnan et al. 53 used in vitro binding assays to study the interaction between TNPO3 and several IN proteins from various retroviruses, such as HIV, MuLV and SIV. A comparison of their results to the infectivity profiles of HIV chimera viruses led them to conclude that the dominant protein dictating TNPO3 dependency during virus infection is the HIV-1 CA and not IN. 53 This conclusion was further supported by a work published during the preparation of this ms. 34 However, no direct or indirect interaction between TNPO3 and CA has yet been demonstrated. The ability to block virus infection by a peptide belonging to either the first or second group clearly indicates that for efficient infection, nuclear import of IN should be mediated at the same time by both nuclear receptors. However, it appears that in IN-expressing cells, as opposed to virus-infected cells, nuclear import via the importin α pathway is dominant. This is inferred from the results showing significant inhibition of IN nuclear import by a peptide belonging to the first group, whereas inhibition was only partial by a peptide belonging to the second group. Thus it appears, as also indicated in our previous observations, 42 that results obtained in transfected cells are not necessarily relevant to those obtained in infected ones.
Our results demonstrate that IN, a karyophilic protein, is translocated into the cell nucleus by two distinct and different nuclear-import pathways. Confirming previous observations, 18, 42 we show that blocking IN nuclear import simultaneously inhibits import of viral cDNA and the formation of 2LTR circles. These results strengthen the view that IN is an integral part of the PIC. 3 It is thus conceivable that participation of the two nuclear-import receptors is required to allow efficient nuclear import of the relatively large PIC, whose main component is the IN-DNA complex: the function of only one of these receptors does not appear to be sufficient to drive the translocation of this IN-DNA complex via the NPC.
It is still unclear why nuclear import of IN requires the involvement of both importin α and TNPO3. Furthermore, Rev-expressing HeLa TZM-bl cells 50 were generated by stable transfection 60 into TZM-bl cells of plasmid pcDNA3.1 bearing the full-length wild-type IN or Rev gene, respectively. Selection was carried out for 4 weeks with 400 µg/ml hygromycin B.
Viruses. Wild-type HIV-1 was generated by transfection of HEK293T cells with pSVC21 plasmid containing the full-length HIV-1 HXB2 viral DNA. Wild-type viruses were harvested from HEK293T cells 48 and 72 h post-transfection. The viruses were stored at -75°C.
Virus stock titration. Quantitative titration of HIV-1 was carried out using the MAGI assay, as described by Kimpton and Emerman. 61 Briefly, TZM-b1 cells were grown in 96-well plates at 1 x 10 4 cells per well. The cells were then infected with 50 µl of serially diluted virus as described. 61 Two days post-infection (PI), cultured cells were fixed and β-galactosidase was estimated exactly as described previously. 61 Blue cells were counted under a light microscope at 200X magnification.
Synthesis of peptides. Peptides were synthesized on Rink amide resin using a model 433A Applied Biosystems peptide synthesizer as described. 62 The Pen peptide, 63 with the following sequence: RQIKIWFQNRRMKWKK (Ant 43-58), was added to the SV40-NLS-and NLS-IN-bearing peptides to allow their cell permeability as described previously. 18 Immunostaining studies. Localization of IN and Rev in transfected cultured cells. TZM-bl IN-or Rev-expressing cells were grown on chamber slides (Nunc). After reaching 70-80% confluence, cell cycle arrest was obtained by treatment with 5 µg/ml of aphidicolin. The cells were then incubated with 150 µM of the indicated peptide for 6 h and fixed and immunostained we still do not know whether the same IN molecule interacts, via different domains, with both receptors or if different IN molecules-or IN oligomers-interact individually with each receptor. The scheme in Figure 7B summarizes our view of the three alternative interaction possibilities between IN and the two nuclear-import receptors importin α and TNPO3.
In addition to importin α and TNPO3, there are two additional pathways that have been implicated in PIC nuclear transport. These include the nuclear import receptor importin 7, 19, 20, 55 and the direct interaction with Nup153, 34, 56 which is one of the NPC proteins. 57 The current results as well as previous results 20, 21, 34, 52, 56, 58 may imply that these two pathways could also be required to ensure PIC nuclear transport as a multi nuclear import complex. Thus, inhibition of only one of these nuclear import pathways should result in partial decrease in the level of the HIV PIC nuclear import but should not block it completely.
Materials and Methods
Mammalian cells. Monolayer adherent HeLa TZM-bl cells (obtained through the NIH AIDS Research and Reference
Reagent Program) expressing the β-galactosidase gene under regulation of a transactivation response element 59 were grown in Dulbecco's modified Eagle's medium. The T-lymphocyte cell line SupT1 was grown in RPMI 1640. All media were supplemented with 10% (v/v) fetal calf serum, 0.3 g/l L-glutamine, 100 units/ml penicillin and 100 units/ml streptomycin (Biological Industries, Beit Haemek, Israel). Cells were incubated at 37°C in a 5% CO 2 atmosphere and re-cultured every 4 days. IN-and antibodies and then with the complementary HRP-conjugated antibodies (Jackson) as second antibodies.
When peptides were used, cells were incubated with 150 µM of the indicated peptide for 2 h prior to infection.
Isolation of cytoplasm and nuclei from infected cells. The various fractions were obtained from virus-infected cells essentially as described previously 44, 66 with several modifications. Briefly, cells were harvested and washed twice in buffer A (20 mM Hepes pH 7.3, 150 mM KCl, 5 mM MgCl 2 , 1 mM DTT and 0.1 mM PMSF). Cells were then suspended in 200 µl of buffer A containing 0.025% (w/v) digitonin, incubated at room temperature for 10 min and then centrifuged for 3 min at 1,000 g at room temperature. The supernatant was then centrifuged at 8,000 g and separated into supernatant (cytoplasm) and pellet (nuclei) and stored at -70 o C.
Quantitation of total and nuclear viral DNA. Total viral DNA was estimated, using SYBR green real-time quantitative PCR at 10 h PI, from the total cell lysate or nuclear-isolated fractions of the infected cells. DNA was isolated by phenol chloroform method. DNA samples (1 µg) were added to 95 µl containing 1X Hot-Rescue Real Time PCR Kit-SG (Diatheva s.r.l, Fano, Italy) and 100 nM of each primer-binding site primer: F5 (5' primer, 5'-TAG CAG TGG CGC CCG A-3') and R5 (3' primer, 5'-TCT CTC TCC TTC TAG CCT CCG C-3'). All amplification reactions were carried out using an ABI Prism 7700 Sequence Detection System (Applied Biosystems) under the following program: 1 cycle at 95°C for 10 min, followed by 45 cycles of 15 s at 95°C and 35 s at 68°C. Three replicates were performed for each PCR run. All other details are exactly as described in Casabianca et al. 67 Quantitation of 2LTR circles. Quantification of 2LTR circles was estimated exactly as described in Butler et al. 68 All experiments were repeated three to four times and the quantitative differences between the experiments never exceeded ±10%.
